Literature DB >> 25275775

Thalidomide-induced orofacial neuropathy.

Cynthia O Anyanwu1, Campbell L Stewart, Victoria P Werth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25275775      PMCID： PMC4442672          DOI： 10.1097/RHU.0000000000000176

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  9 in total

1.  Thalidomide-induced perioral neuropathy.

Authors:  S Elad; D Galili; A A Garfunkel; R Or
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-10

2.  Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".

Authors:  Jeffrey P Callen
Journal:  JAMA Dermatol       Date:  2013-09       Impact factor: 10.282

Review 3.  Thalidomide: dermatological indications, mechanisms of action and side-effects.

Authors:  J J Wu; D B Huang; K R Pang; S Hsu; S K Tyring
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

4.  Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.

Authors:  R D Sontheimer; J R Thomas; J N Gilliam
Journal:  Arch Dermatol       Date:  1979-12

5.  Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden.

Authors:  C M Grönhagen; C M Fored; M Linder; F Granath; F Nyberg
Journal:  Br J Dermatol       Date:  2012-07-05       Impact factor: 9.302

6.  Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

Authors:  David C Johnson; Sophie L Corthals; Brian A Walker; Fiona M Ross; Walter M Gregory; Nicholas J Dickens; Henk M Lokhorst; Hartmut Goldschmidt; Faith E Davies; Brian G M Durie; Brian Van Ness; J Anthony Child; Pieter Sonneveld; Gareth J Morgan
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

7.  Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

Authors:  Sylvie Bastuji-Garin; Sophie Ochonisky; Pierre Bouche; Romain K Gherardi; Corinne Duguet; Zaya Djerradine; Florence Poli; Jean Revuz
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

8.  Thalidomide-induced neuropathy.

Authors:  V Chaudhry; D R Cornblath; A Corse; M Freimer; E Simmons-O'Brien; G Vogelsang
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

9.  Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy.

Authors:  B R Reed; J C Huff; S K Jones; P W Orton; L A Lee; D A Norris
Journal:  Ann Intern Med       Date:  1985-07       Impact factor: 25.391
  9 in total
  3 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

Review 2.  Subacute cutaneous lupus erythematosus inducing unilateral sensorimotor neuropathy.

Authors:  Savvas Psarelis; Fanourios Georgiades; Antreas Ioannou; Eleni Xenophontos; Georgios Georgiou; Eleni Papanicolaou
Journal:  Rheumatol Int       Date:  2016-11-25       Impact factor: 2.631

3.  Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; Beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrome after intra-articular glucocorticoid injection; troponin leak associated with drug-induced methemoglobinemia.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.